Banned cough syrup case: Allahabad HC grants interim bail to two brothers

Published On 2025-12-24 07:00 GMT | Update On 2025-12-24 07:00 GMT

Allahabad High Court

Lucknow: Granting interim relief in a high-profile banned cough syrup case, the Allahabad High Court has granted interim bail to two brothers, observing that no recovery was made from their possession.

Justice Karunesh Singh Pawar of the Lucknow bench passed orders on December 18 on separate bail applications by Vibhor Rana and Vishal Singh, who were arrested on November 13 for allegedly diverting stock of Phensedyl cough syrup. He has fixed January 5 as the next date of hearing.

Earlier, the state government vehemently opposed their bail pleas and sought time to file its reply.

While granting the interim bail, the court noted that in this case, three other accused -- Shailendra Arya, from whose truck the banned medicine was recovered, Pawan Gupta and Devendra Kumar Vishwakarma -- have already been granted bail.

It also noted that in a similar case, the accused were granted relief by discharging them on the ground that no offence was made out under the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

As per PTI, the court said the names of the accused persons came to light on the basis of statements of co-accused Bittu Kumar and Sachin Kumar, but no recovery was made from them.

The court asked the two accused to cooperate in the investigation during the period of their interim bail and that they would make themselves available as and when required by the investigating officer. During this period, it said, the accused would not tamper with prosecution evidence.

Read also: Codeine syrup smuggling case: Rs 50,000 reward, lookout notice issued against key accused

Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Banned cough syrup case: Allahabad HC grants interim bail to two brothers

Similar News

Five Pharma Firms Under Regulatory Scanner Over Rs 8 Lakh Unbilled Medicines

Pharma Crackdown in South Delhi: 26 Firms Booked, 265 Drug Samples Lifted

Quadria Capital sells entire stake in Akums for Rs 311 crore

Codeine syrup smuggling case: Rs 50,000 reward, lookout notice issued against key accused

Zydus to commercialize Vascular Endothelial Growth Factor inhibitor Nufymco in US

Emcure Pharma gets USFDA EIR for Gujarat facility

State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November